Jakob Eberhard

4.3k total citations
128 papers, 3.2k citations indexed

About

Jakob Eberhard is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Jakob Eberhard has authored 128 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 47 papers in Surgery and 27 papers in Molecular Biology. Recurrent topics in Jakob Eberhard's work include Pelvic floor disorders treatments (20 papers), Pancreatic and Hepatic Oncology Research (20 papers) and Testicular diseases and treatments (18 papers). Jakob Eberhard is often cited by papers focused on Pelvic floor disorders treatments (20 papers), Pancreatic and Hepatic Oncology Research (20 papers) and Testicular diseases and treatments (18 papers). Jakob Eberhard collaborates with scholars based in Sweden, Switzerland and Germany. Jakob Eberhard's co-authors include Karin Jirström, Björn Nodin, Mathias Uhlén, Volker Viereck, Jonna Berntsson, Sakarias Wangefjord, Verena Geissbühler, Patrick Micke, Alexander Gaber and Aleksander Giwercman and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Jakob Eberhard

123 papers receiving 3.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jakob Eberhard 920 873 855 433 378 128 3.2k
Paola Grammatico 584 0.6× 696 0.8× 1.8k 2.1× 315 0.7× 388 1.0× 204 4.4k
Yukihiro Hasegawa 579 0.6× 608 0.7× 2.1k 2.5× 296 0.7× 303 0.8× 258 5.0k
Päivi J. Miettinen 1.0k 1.1× 1.1k 1.2× 2.5k 2.9× 148 0.3× 210 0.6× 90 4.6k
Pablo Lapunzina 462 0.5× 589 0.7× 2.9k 3.3× 518 1.2× 206 0.5× 227 5.1k
Marina Colombi 478 0.5× 477 0.5× 1.1k 1.2× 489 1.1× 140 0.4× 181 3.7k
Eberhard Passarge 729 0.8× 620 0.7× 2.2k 2.6× 193 0.4× 121 0.3× 158 4.1k
Jin Sun Lee 758 0.8× 200 0.2× 454 0.5× 235 0.5× 155 0.4× 101 2.1k
Dirk Schnabel 509 0.6× 408 0.5× 2.0k 2.3× 494 1.1× 189 0.5× 120 4.8k
Zachary Thompson 492 0.5× 560 0.6× 770 0.9× 94 0.2× 163 0.4× 80 2.8k
Ora Hirsch Pescovitz 251 0.3× 382 0.4× 1.6k 1.8× 525 1.2× 234 0.6× 137 4.6k

Countries citing papers authored by Jakob Eberhard

Since Specialization
Citations

This map shows the geographic impact of Jakob Eberhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakob Eberhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakob Eberhard more than expected).

Fields of papers citing papers by Jakob Eberhard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakob Eberhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakob Eberhard. The network helps show where Jakob Eberhard may publish in the future.

Co-authorship network of co-authors of Jakob Eberhard

This figure shows the co-authorship network connecting the top 25 collaborators of Jakob Eberhard. A scholar is included among the top collaborators of Jakob Eberhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakob Eberhard. Jakob Eberhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Eberhard, Jakob, Jenny Karlsson, Subhayan Chattopadhyay, et al.. (2022). Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Cancer. Molecular Cancer Research. 20(5). 749–761. 5 indexed citations
5.
Viðarsdóttir, Halla, Björn Nodin, Per Jönsson, et al.. (2021). Clinical significance of RBM3 expression in surgically treated colorectal lung metastases and paired primary tumors. Journal of Surgical Oncology. 123(4). 1144–1156. 6 indexed citations
6.
Hansen, Torben Frøstrup, Eva Fernebro, John Pløen, et al.. (2021). Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations. International Journal of Cancer. 149(1). 119–126. 10 indexed citations
7.
Lundgren, Sebastian, Emelie Karnevi, Jacob Elebro, et al.. (2017). The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype. Journal of Translational Medicine. 15(1). 152–152. 26 indexed citations
8.
Hedner, Charlotta, David Borg, Björn Nodin, et al.. (2017). Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment. Journal of Clinical Pathology. 71(5). 451–462. 9 indexed citations
10.
Lundgren, Sebastian, Jacob Elebro, Margareta Heby, et al.. (2016). The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment. PLoS ONE. 11(6). e0156497–e0156497. 28 indexed citations
11.
Elebro, Jacob, et al.. (2016). Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma. PLoS ONE. 11(4). e0153533–e0153533. 20 indexed citations
12.
Hedner, Charlotta, Lena Tran, David Borg, et al.. (2015). Discordant human epidermal growth factor receptor 2 overexpression in primary and metastatic upper gastrointestinal adenocarcinoma signifies poor prognosis. Histopathology. 68(2). 230–240. 18 indexed citations
13.
Chimienti, Milena, et al.. (2009). Marché du sexe en Suisse. Etat des connaissances, best practices et recommandations, Volet 3 – Mapping, contrôle et promotion de la santé dans le marché du sexe en Suisse. Archive ouverte UNIGE (University of Geneva). 1 indexed citations
14.
Viereck, Volker & Jakob Eberhard. (2008). Inkontinenzoperationen - Indikationen, Auswahl der Operationsmethode, Operationstechnik, Umgang mit Früh- und Spätkomplikationen. Zurich Open Repository and Archive (University of Zurich). 15(3). 37–42.
15.
Petri, E., H. Kölbl, & Jakob Eberhard. (2001). Operative Konzepte bei der weiblichen Harninkontinenz. Zentralblatt für Gynäkologie. 123(12). 689–698. 3 indexed citations
16.
Eberhard, Jakob, et al.. (2000). Konservative und operative Therapie bei Harninkontinenz Deszensus und Urogenitalbschwerden. Journal für Kardiologie (Krause & Pachernegg GmbH). 7(3). 22–35. 2 indexed citations
17.
Eberhard, Jakob, et al.. (2000). Urogenitalproblematik und Harninkontinenz im Alter - Wirkungen von Östrogenen. Journal für Kardiologie (Krause & Pachernegg GmbH). 7(1). 27–31. 4 indexed citations
18.
Eberhard, Jakob, et al.. (1980). Morphological changes after surgical treatment of urinary incontinence stages II and III. Archives of Gynecology and Obstetrics. 229(3). 197–205. 2 indexed citations
19.
Eberhard, Jakob, et al.. (1978). [The diagnosis of urinary incontinence in gynaecology. Indications for urodynamic diagnosis and description of urodynamic diagnostic apparatus (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(5). 352–60. 3 indexed citations
20.
Eberhard, Jakob, et al.. (1977). Die kindliche Entwicklung nach vaginaler und abdominaler Entbindung bei Beckenendlagen. Archives of Gynecology and Obstetrics. 224(1-4). 247–247. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026